The sensitivity of human bone marrow granulocyte/monocyte precursor cells to phenylbutazone, oxyphenbutazone and gamma-hydroxyphenylbutazone in vitro, with observations on the bone marrow colony formation in phenylbutazone-induced granulocytopoenia.
D000328:Adult; D000368:Aged; D000380:Agranulocytosis / Q000139:chemically induced / Q000473:pathology*; D001853:Bone Marrow / Q000187:drug effects / Q000473:pathology; D001854:Bone Marrow Cells; D001855:Bone Marrow Diseases / Q000139:chemically induced / Q000473:pathology; D003864:Depression, Chemical; D005260:Female; D006098:Granulocytes / Q000166:cytology / Q000187:drug effects*; D006801:Humans; D066298:In Vitro Techniques; D007962:Leukocytes / Q000187:drug effects*; D008875:Middle Aged; D009000:Monocytes / Q000166:cytology / Q000187:drug effects*; D010113:Oxyphenbutazone / Q000494:pharmacology*; D010653:Phenylbutazone / Q000009:adverse effects / Q000031:analogs & derivatives* / Q000494:pharmacology*; D013997:Time Factors
D010653:Phenylbutazone; D010113:Oxyphenbutazone